For any serious researcher, understanding this distinction isn't just helpfulit's absolutely critical for designing valid, targeted, and reproducible studies
Look for any disciplinary actions or warning letters
Francis S Willard, et al., Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist, Journal of Critical Investigation, published Jul 30, 2020
Its stability drops dramatically the moment it's mixed with a liquid, and at that point, refrigeration isn't just a suggestionit's a non-negotiable requirement
Whats the difference between the GLP-1s on the market
Daily Dietary Protein Distribution Does Not Influence Changes in Body Composition During Weight Loss in Women of Reproductive Years with Overweight or Obesity: A Randomized Controlled Trial